Variant report

Variant	esv2762417
Chromosome Location	chr4:26491768-26576800
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:530)
CpG islands
(count:732)
Chromatin interactive
region (count:14)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:530 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:26570412-26570688	K562	blood:	n/a	n/a
2	ARID3A	chr4:26502088-26502372	HepG2	liver:	n/a	n/a
3	ATF1	chr4:26513509-26513741	K562	blood:	n/a	n/a
4	ATF1	chr4:26522374-26522616	K562	blood:	n/a	n/a
5	ATF3	chr4:26502224-26502398	HepG2	liver:	n/a	n/a
6	ATF3	chr4:26501964-26502751	HCT-116	colon:	n/a	n/a
7	ATF3	chr4:26569867-26570751	HCT-116	colon:	n/a	n/a
8	ATF3	chr4:26569797-26570611	HCT-116	colon:	n/a	n/a
9	ATF3	chr4:26502144-26502457	HepG2	liver:	n/a	n/a
10	BACH1	chr4:26535810-26535826	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr4:26540109-26540119	H1-hESC	embryonic stem cell:	n/a	n/a
12	BHLHE40	chr4:26573491-26573607	K562	blood:	n/a	n/a
13	BHLHE40	chr4:26513528-26513737	K562	blood:	n/a	n/a
14	BHLHE40	chr4:26502259-26502926	K562	blood:	n/a	n/a
15	BHLHE40	chr4:26502064-26502930	HepG2	liver:	n/a	n/a
16	BHLHE40	chr4:26522938-26522965	K562	blood:	n/a	n/a
17	CBX3	chr4:26561515-26561879	HCT-116	colon:	n/a	n/a
18	CBX3	chr4:26569653-26570862	HCT-116	colon:	n/a	n/a
19	CBX3	chr4:26569802-26570838	HCT-116	colon:	n/a	n/a
20	CEBPB	chr4:26569753-26570792	HCT-116	colon:	n/a	n/a
21	CEBPB	chr4:26560140-26560461	IMR90	lung:	n/a	chr4:26560309-26560320
22	CEBPB	chr4:26502159-26502490	HepG2	liver:	n/a	chr4:26502320-26502331
23	CEBPB	chr4:26502251-26502480	K562	blood:	n/a	chr4:26502320-26502331
24	CEBPB	chr4:26574336-26574536	IMR90	lung:	n/a	n/a
25	CEBPB	chr4:26560221-26560421	K562	blood:	n/a	chr4:26560309-26560320
26	CEBPB	chr4:26502164-26502638	IMR90	lung:	n/a	chr4:26502320-26502331
27	CEBPB	chr4:26502097-26502649	MCF-7	breast:	n/a	chr4:26502320-26502331
28	CEBPB	chr4:26502160-26502481	HepG2	liver:	n/a	chr4:26502320-26502331
29	CEBPB	chr4:26558727-26559216	IMR90	lung:	n/a	n/a
30	CEBPB	chr4:26543402-26543486	K562	blood:	n/a	n/a
31	CEBPB	chr4:26569734-26570964	HCT-116	colon:	n/a	n/a
32	CEBPB	chr4:26526787-26527169	IMR90	lung:	n/a	n/a
33	CEBPB	chr4:26501851-26502993	HCT-116	colon:	n/a	chr4:26502320-26502331
34	CEBPB	chr4:26501969-26502874	HCT-116	colon:	n/a	chr4:26502320-26502331
35	CEBPB	chr4:26558735-26559100	ECC-1	luminal epithelium:	n/a	n/a
36	CEBPB	chr4:26569951-26570393	A549	lung:	n/a	n/a
37	CEBPB	chr4:26502138-26502593	MCF-7	breast:	n/a	chr4:26502320-26502331
38	CEBPB	chr4:26560151-26560450	HepG2	liver:	n/a	chr4:26560309-26560320
39	CEBPB	chr4:26560156-26560388	A549	lung:	n/a	chr4:26560309-26560320
40	CEBPB	chr4:26502084-26502681	Hela-S3	cervix:	n/a	chr4:26502320-26502331
41	CEBPB	chr4:26569925-26570999	Hela-S3	cervix:	n/a	n/a
42	CEBPB	chr4:26502236-26502402	HepG2	liver:	n/a	chr4:26502320-26502331
43	CEBPB	chr4:26569909-26570605	IMR90	lung:	n/a	n/a
44	CEBPB	chr4:26502180-26502572	A549	lung:	n/a	chr4:26502320-26502331
45	CTCF	chr4:26557552-26557640	ProgFib	skin:	n/a	n/a
46	CTCF	chr4:26575038-26575141	Hela-S3	cervix:	n/a	n/a
47	CTCF	chr4:26498002-26498159	ProgFib	skin:	n/a	chr4:26498068-26498077
48	CTCF	chr4:26574994-26575151	MCF-7	breast:	n/a	n/a
49	CTCF	chr4:26497960-26498110	HBMEC	blood vessel:	n/a	chr4:26498068-26498077
50	CTCF	chr4:26574940-26575090	HCPEpiC	choroid plexus:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:26492488-26492538	GM12892	blood:	n/a
2	chr4:26493496-26493546	AG10803	skin:	n/a
3	chr4:26491963-26492013	HL-60	blood:	n/a
4	chr4:26493496-26493546	HNPCEpiC	eye:	n/a
5	chr4:26492378-26492428	ECC-1	luminal epithelium:	n/a
6	chr4:26559501-26559551	HCT-116	colon:	n/a
7	chr4:26559501-26559551	CMK	blood:	n/a
8	chr4:26575624-26575674	GM12878	blood:	n/a
9	chr4:26493496-26493546	NB4	blood:	n/a
10	chr4:26492378-26492428	AG09309	skin:	n/a
11	chr4:26492421-26492471	PANC-1	pancreas:	n/a
12	chr4:26492206-26492256	SKMC	muscle:	n/a
13	chr4:26493496-26493546	HEK293	kidney:	embryo
14	chr4:26493496-26493546	Caco-2	colon:	n/a
15	chr4:26525187-26525237	HRCEpiC	kidney:	n/a
16	chr4:26492488-26492538	HCPEpiC	choroid plexus:	n/a
17	chr4:26492488-26492538	SK-N-MC	brain:	n/a
18	chr4:26492378-26492428	LNCaP	prostate:	n/a
19	chr4:26492222-26492272	HL-60	blood:	n/a
20	chr4:26493496-26493546	Hepatocyte	liver:	n/a
21	chr4:26492206-26492256	PANC-1	pancreas:	n/a
22	chr4:26575624-26575674	GM12891	blood:	n/a
23	chr4:26575624-26575674	NB4	blood:	n/a
24	chr4:26492206-26492256	HEEpiC	esophagus:	n/a
25	chr4:26491963-26492013	HepG2	liver:	n/a
26	chr4:26559501-26559551	HPAEpiC	pulmonary alveolar:	n/a
27	chr4:26492206-26492256	AG04450	lung:	fetal
28	chr4:26492206-26492256	GM12892	blood:	n/a
29	chr4:26492870-26492920	NT2-D1	testis:	n/a
30	chr4:26525187-26525237	HEK293	kidney:	embryo
31	chr4:26559501-26559551	Caco-2	colon:	n/a
32	chr4:26492153-26492203	NT2-D1	testis:	n/a
33	chr4:26559501-26559551	AG10803	skin:	n/a
34	chr4:26492378-26492428	HCT-116	colon:	n/a
35	chr4:26492153-26492203	HCPEpiC	choroid plexus:	n/a
36	chr4:26492488-26492538	HL-60	blood:	n/a
37	chr4:26492870-26492920	GM12892	blood:	n/a
38	chr4:26492488-26492538	HCM	heart:	n/a
39	chr4:26559501-26559551	HCPEpiC	choroid plexus:	n/a
40	chr4:26492206-26492256	HUVEC	blood vessel:	n/a
41	chr4:26492222-26492272	PFSK-1	brain:	n/a
42	chr4:26492378-26492428	SK-N-SH	brain:	n/a
43	chr4:26492206-26492256	NHDF-neo	bronchial:	n/a
44	chr4:26493496-26493546	GM12891	blood:	n/a
45	chr4:26575624-26575674	H1-hESC	embryonic stem cell:	embryo
46	chr4:26492870-26492920	PFSK-1	brain:	n/a
47	chr4:26492153-26492203	HMEC	breast:	n/a
48	chr4:26492222-26492272	SKMC	muscle:	n/a
49	chr4:26525187-26525237	AG04450	lung:	fetal
50	chr4:26491963-26492013	HRPEpiC	eye:	n/a

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:26572403..26575224-chr4:26584426..26586030,2	MCF-7	breast:
2	chr4:26522451..26525005-chr4:26526111..26528805,2	MCF-7	breast:
3	chr4:26538201..26539998-chr4:26544249..26546100,2	K562	blood:
4	chr4:26518185..26518917-chr8:100791052..100791908,2	MCF-7	breast:
5	chr4:26508505..26510474-chr4:26511575..26514070,2	K562	blood:
6	chr4:26567486..26569204-chr4:26569511..26572156,2	K562	blood:
7	chr4:26520589..26522525-chr4:26524809..26527175,2	K562	blood:
8	chr4:26508505..26510474-chr4:26511575..26514070,2	K562	blood:
9	chr4:26538493..26540713-chr4:26542222..26544962,2	K562	blood:
10	chr4:26522451..26525005-chr4:26526111..26528805,2	MCF-7	breast:
11	chr4:26538493..26540713-chr4:26542222..26544962,2	K562	blood:
12	chr4:26538201..26539998-chr4:26544249..26546100,2	K562	blood:
13	chr4:26567486..26569204-chr4:26569511..26572156,2	K562	blood:
14	chr4:26520589..26522525-chr4:26524809..26527175,2	K562	blood:

No data

Variant related genes	Relation type
TBC1D19	TF binding region
CCKAR	TF binding region
TBC1D19	CpG island
CCKAR	CpG island
ENSG00000109680	chromatin interactions

Extended variants
information (count: 2844 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:2844 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1800856	chr4:26491768-26491769	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs550581286	chr4:26491769-26491770	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs567297961	chr4:26491771-26491772	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs200494718	chr4:26491781-26491782	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs536379349	chr4:26491790-26491791	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs61730704	chr4:26491793-26491794	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs149993603	chr4:26491817-26491818	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs202031212	chr4:26491818-26491819	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs104893833	chr4:26491829-26491830	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs115609834	chr4:26491830-26491831	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs116476903	chr4:26491831-26491832	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs200917200	chr4:26491854-26491855	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs201856546	chr4:26491867-26491868	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs199975181	chr4:26491875-26491876	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs537322039	chr4:26491889-26491890	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs200849488	chr4:26491901-26491902	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs201796699	chr4:26491913-26491914	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs200119191	chr4:26491914-26491915	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs201179899	chr4:26491923-26491924	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs41267459	chr4:26491926-26491927	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs202039613	chr4:26491941-26491942	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs377488910	chr4:26491944-26491945	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs200488470	chr4:26491957-26491958	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs201586028	chr4:26491964-26491965	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs6448456	chr4:26491974-26491975	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs545284669	chr4:26491976-26491977	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs200177038	chr4:26491990-26491991	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs190188968	chr4:26492006-26492007	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
29	rs181156950	chr4:26492018-26492019	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
30	rs201311032	chr4:26492030-26492031	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
31	rs560986896	chr4:26492041-26492042	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs199694452	chr4:26492080-26492081	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
33	rs373086084	chr4:26492096-26492097	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs36224751	chr4:26492104-26492105	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs186654279	chr4:26492130-26492131	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs115646101	chr4:26492153-26492154	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs376084549	chr4:26492154-26492155	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs1799723	chr4:26492175-26492176	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs1800908	chr4:26492222-26492223	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs537385343	chr4:26492252-26492253	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs34278598	chr4:26492261-26492262	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs35281481	chr4:26492262-26492263	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs74531659	chr4:26492298-26492299	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs557291870	chr4:26492309-26492310	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs573936940	chr4:26492311-26492312	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs535881498	chr4:26492314-26492315	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs4349588	chr4:26492362-26492363	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs572870367	chr4:26492363-26492364	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs36224747	chr4:26492372-26492373	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs36224746	chr4:26492377-26492378	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
Oral squamous cell carcinoma	17134496	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Lung cancer	18438408	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21858162	CNVD
small cell lung cancer	20016488	CNVD
Cancer	21183584	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Breast cancer	17133270	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Olfactory neuroblastoma	18408657	CNVD
Burkitt''s lymphoma	20823134	CNVD
Cancer	22183965	CNVD
Gastric cancer	16891809	CNVD
Myelofibrosis	22110671	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:407 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:26490600-26492000	Active TSS	Gastric	stomach
2	chr4:26490600-26492400	Bivalent Enhancer	Fetal Brain Male	brain
3	chr4:26490800-26492000	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr4:26490800-26492200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr4:26490800-26492600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr4:26491000-26492600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr4:26491200-26493000	Enhancers	Fetal Lung	lung
8	chr4:26491400-26491800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr4:26491400-26491800	Bivalent/Poised TSS	Fetal Stomach	stomach
10	chr4:26491400-26492200	Bivalent Enhancer	Brain Germinal Matrix	brain
11	chr4:26491400-26492400	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr4:26491400-26492600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
13	chr4:26491400-26494600	Weak transcription	Right Atrium	heart
14	chr4:26491600-26491800	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr4:26491800-26492000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr4:26491800-26492200	Active TSS	Fetal Brain Female	brain
17	chr4:26491800-26492200	Flanking Bivalent TSS/Enh	Fetal Stomach	stomach
18	chr4:26492000-26492200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr4:26492000-26492400	Enhancers	Fetal Heart	heart
20	chr4:26492000-26492600	Bivalent Enhancer	Fetal Muscle Leg	muscle
21	chr4:26492000-26495000	Weak transcription	Gastric	stomach
22	chr4:26492000-26504200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr4:26492200-26492400	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
24	chr4:26492200-26492400	Flanking Active TSS	Fetal Brain Female	brain
25	chr4:26492200-26492400	Bivalent Enhancer	Fetal Stomach	stomach
26	chr4:26492200-26492400	Bivalent Enhancer	Stomach Mucosa	stomach
27	chr4:26492200-26492800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr4:26492400-26492600	Enhancers	Duodenum Smooth Muscle	Duodenum
29	chr4:26492400-26492600	Enhancers	Fetal Brain Female	brain
30	chr4:26492400-26492600	Bivalent Enhancer	Stomach Smooth Muscle	stomach
31	chr4:26492400-26493000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr4:26492400-26493000	Bivalent Enhancer	Brain Germinal Matrix	brain
33	chr4:26492600-26493600	Enhancers	Cortex derived primary cultured neurospheres	brain
34	chr4:26493000-26493600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr4:26493000-26493600	Weak transcription	Fetal Lung	lung
36	chr4:26493600-26493800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
37	chr4:26493600-26493800	Enhancers	Fetal Lung	lung
38	chr4:26493600-26493800	Bivalent Enhancer	Fetal Stomach	stomach
39	chr4:26495000-26495200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr4:26495000-26495600	Active TSS	Gastric	stomach
41	chr4:26495000-26495800	Enhancers	Fetal Muscle Leg	muscle
42	chr4:26495200-26495400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr4:26497000-26497200	Enhancers	Fetal Kidney	kidney
44	chr4:26497800-26498000	Enhancers	Muscle Satellite Cultured Cells	--
45	chr4:26497800-26498400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr4:26497800-26498400	Enhancers	Osteobl	bone
47	chr4:26498400-26502000	Weak transcription	Osteobl	bone
48	chr4:26501800-26503200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr4:26502000-26503200	Enhancers	Muscle Satellite Cultured Cells	--
50	chr4:26502000-26503200	Enhancers	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links